Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

The Biggest News of 2018: TCTMD’s Top 10

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

December 31, 2018

Top News in Endovascular Therapy: 2018

News Features

Top News in Endovascular Therapy: 2018

December 28, 2018

Top News in Policy & Practice: 2018

News Features

Top News in Policy & Practice: 2018

December 28, 2018

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

December 18, 2018

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

December 17, 2018

TCTMD’s Top 10 Most Popular Stories for October 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

October 31, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

October 05, 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

September 24, 2018

Smartphone Heart Rate-Monitoring App Can Accurately Assess Radial Artery Patency

News Daily News

Smartphone Heart Rate-Monitoring App Can Accurately Assess Ulnar Artery Patency

April 03, 2018

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.